Advertisement

PharmacoEconomics & Outcomes News

, Volume 422, Issue 1, pp 7–7 | Cite as

Oprelvekin “not worth the cost” for thrombocytopenia prophylaxis

Clinical study
  • 6 Downloads

Keywords

Thrombocytopenia Usual Care Outcome News Platelet Transfusion Pharmacoeconomic Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations